// App-Quantinova.ai

3491 : Rational combination of targeted agents and BH3 mimetics to improve cancer treatment

Researchers

Presenter

  • Joan Montero

Principal Investigators

  • Dorota E. Sadowicz

  • Jeremy Ryan

  • Charles H. Yoon

  • Rizwan Haq

  • Anthony Letai

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • GC Vitamin D Binding Protein

Drug/Treatment

  • Dabrafenib Mesylate

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved